Q2 2020 Heidelberg Pharma AG Earnings Call Transcript
Good afternoon, and welcome to the Heidelberg Pharma Half-Yearly Financial Report 2020. The call will be hosted by Dr. Jan Schmidt-Brand, CEO and CFO of Heidelberg Pharma AG. My name is Anika, and I'll be your coordinator for today's conference. (Operator Instructions)
I'm now handing you over to your host, Dr. Jan Schmidt-Brand, CEO and CFO, to begin today's conference. Please go ahead.
Thank you, Anika. Hello, ladies and gentlemen. Welcome to the Heidelberg Pharma Press, Analysts and Investors Conference Call to discuss our financial results for the first half 2020 and to provide a business update. My name is Jan Schmidt-Brand, I'm CEO and CFO of the company. Joining me on the call today are my colleagues, Professor Andreas Pahl, Chief Scientific Officer; and Katja Arnold, our Investor Relations Consultant.
Please note that this presentation is available for download on the Heidelberg Pharma website. This conference call is
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |